Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EBR/ARGX stock hub

EBR/ARGX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EBR/ARGXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

41.7B

Euronext Brussels

Market data

Live price

Current market quote for this ticker.

Current price

EBR/ARGX

In the news

Latest news · EBR/ARGX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.9

P25 15.5P50 19.3P75 22.9

Trailing P/E34.4

P25 15.4P50 24.5P75 34.5

ROEn/a

P25 -36.4P50 10P75 16.6

ROIC44.3

P25 -46.8P50 -7.8P75 14

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EBR/ARGX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	BE
Employees	1,863
Employees Change	264%
Employees Change Percent	16.51
Enterprise value	EUR 37.9B
Exchange	Euronext Brussels
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	NL0010832176
Last refreshed	2026-05-10
Market cap	EUR 41.7B
Price	EUR 671
Price currency	EUR
Rev Per Employee	2,207,806.42x
Sector	Healthcare
Sic	2836
Symbol	ebr/ARGX
Website	https://argenx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.1%
EV Earnings	29.35x
EV/EBIT	33.69x
EV/EBITDA	33.2x
EV/Sales	9.22x
Forward P/E	25.92x
P/B ratio	6.57x
P/E ratio	34.39x
P/S ratio	10.14x
PEG ratio	0.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.61%
EBITDA Margin	27.8%
Gross margin	58.11%
Gross Profit	EUR 2.4B
Gross Profit Growth	110.26%
Gross Profit Growth Q	79.4%
Net Income	EUR 1.3B
Net Income Growth	39.93%
Net Income Growth Q	115.97%
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Pretax Margin	31.68%
Profit Margin	31.4%
Profit Per Employee	EUR 693,205
Profitable Years	2
Roa5y	-4.42
Roe5y	-3.39
ROIC	44.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	50.31%
Cagr1y	22.87%
Cagr3y	22.54%
Cagr5y	25.09%
EPS Growth	41.13
EPS Growth Q	114
EPS Growth Quarters	5
EPS Growth Years	3
Revenue Growth	79.43x
Revenue Growth Q	62.63x
Revenue Growth Quarters	8x
Revenue Growth Years	3x
Revenue Growth3 Y	95.02x
Revenue Growth5 Y	87.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	EUR 3.9B
Debt	EUR 40.9M
Debt EBITDA	EUR 0.04
Debt Equity	EUR 0.01
Equity	EUR 6.4B
Interest Coverage	412.5
Net Cash	EUR 3.8B
Net Cash By Market Cap	EUR 9.13
Net Cash Growth	31.53%
Net Debt EBITDA	EUR -3.33
Net Debt Equity	EUR -0.6
Tangible Book Value	EUR 6.1B
Tangible Book Value Per Share	EUR 98.82
WACC	3.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	5,784.21%
1Y total return	22.86%
200-day SMA	674.9
3Y total return	84.03%
50-day SMA	650.8
50-day SMA vs 200-day SMA	50under200
5Y total return	206.16%
All Time High	810
All Time High Change	-17.19%
All Time High Date	2025-11-20
All Time Low	6.23
All Time Low Change	10,667.26%
All Time Low Date	2014-10-16
ATR	20.08
Beta	-0.06
Beta1y	0.39
Beta2y	0.14
Ch YTD	-6.42
High	674.4
High52	810
High52 Date	2025-11-20
High52ch	-17.19%
Low	661.2
Low52	456.6
Low52 Date	2025-07-04
Low52ch	46.91%
Ma50ch	3.08%
Price vs 200-day SMA	-0.61%
RSI	50.01
RSI Monthly	58.96
RSI Weekly	50.35
Sharpe ratio	1.04x
Sortino ratio	1.89
Total Return	0.85%
Tr YTD	-6.42
Tr1m	3.42%
Tr1w	-1.99%
Tr3m	-3.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.1B
Operating Income Growth	509
Operating Income Growth Q	178.9
Operating margin	27.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,086,042%
Shares Insiders	0.16%
Shares Institutions	74.66%
Shares Out	62,187,771
Shares Qo Q	-0.11%
Shares Yo Y	-0.85%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	85,609.65x
Bv Per Share	102.6
Ch10y	5,784.2
Ch1m	3.42
Ch1w	-1.99
Ch1y	22.86
Ch3m	-3.57
Ch3y	84.03
Ch5y	206.2
Ch6m	-8.13
Change	-0.06%
Change From Open	-0.09
Close	671.2
Days Gap	0.03
Depreciation Amortization	7,356,282.3
Dollar Volume	63,120,938.4
Earnings Date	2026-05-07
EBIT	EUR 1.1B
EBITDA	EUR 1.1B
EPS	EUR 19.51
F Score	2
Fiscal Year End	December
Founded	2,008
Graham Number	212.24702
Graham Upside	-68.36
Income Tax	EUR 11.8M
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	700.6
Ma150ch	-4.25%
Ma20	684.3
Ma20ch	-1.98%
Next Earnings Date	2026-07-23
Open	671.4
Position In Range	72.73
Price Date	2026-05-08
Price EBITDA	EUR 36.49
Ptbv Ratio	6.82
Relative Volume	1.14x
Revenue	4,113,143,364x
Tax By Revenue	0.29x
Tax Rate	0.9%
Tr6m	-8.13%
Volume	94,098

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EBR/ARGX pay a dividend?

Capital-return profile for this ticker.

Performance

EBR/ARGX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EBR/ARGX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+74.7%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

EBR/ARGX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.0

Neutral momentum band

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

1.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EBR/ARGX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ebr/ARGX stock rating?

ebr/ARGX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ebr/ARGX analysis?

The full report lives at /stocks/ebr/ARGX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ebr/ARGX?

The latest report frames ebr/ARGX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ebr/ARGX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.